| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |